Stephanie Thee
Charité - Universitätsmedizin Berlin
H-index: 22
Europe-Germany
Top articles of Stephanie Thee
Elexacaftor/tezacaftor/ivacaftor improves nasal nitric oxide in patients with cystic fibrosis
Journal of Cystic Fibrosis
2024/3/19
Stephanie Thee
H-Index: 15
Remote endpoints for clinical trials in cystic fibrosis: Report from the US CF foundation remote endpoints task force
2024/2/29
Stephanie Thee
H-Index: 15
A comparative study of airway inflammation and sputum viscoelastic properties in patients with primary ciliary dyskinesia and patients with cystic fibrosis on Elexacaftor …
Klinische Pädiatrie
2024/2
ConneCT CF–Coaching und Telemonitoring für Patienten mit Cystischer Fibrose: Daten der Zwischenauswertung
Klinische Pädiatrie
2024/2
Two-year evolution of nitrogen lung clearance index in patients with primary ciliary dyskinesia
Klinische Pädiatrie
2024/2
Lungenabszess und nekrotisierende Pneumonie–ein Fall für die Kinderpneumologie oder-chirurgie
Klinische Pädiatrie
2024/2
Multiple-breath washout to detect lung disease in patients with inborn errors of immunity
ERJ Open Research
2024/1/1
Stephanie Thee
H-Index: 15
P042 Nasal nitric oxide increases in patients with cystic fibrosis treated with elexacaftor/tezacaftor/ivacaftor
Journal of Cystic Fibrosis
2023/6/1
P020 Therapy with elexacaftor/tezacaftor/ivacaftor in a patient with compound heterozygous CFTR mutation and the complex CFTR-allele Phe508del; Leu467Phe
Journal of Cystic Fibrosis
2023/6/1
P061 FTR-Modulator therapy during pregnancy in a mother with F508del carrier status and high-grade suspicion of cystic fibrosis in the foetus
Journal of Cystic Fibrosis
2023/6/1
EPS6. 01 Effects of elexacaftor/tezacaftor/ivacaftor therapy on sputum viscoelasticity, airway infection and inflammation in patients with cystic fibrosis
Journal of Cystic Fibrosis
2023/6/1
Tuberkulose–Update 2022
Monatsschrift Kinderheilkunde
2023/6
Katharina Kainz
H-Index: 10
Stephanie Thee
H-Index: 15
Effects of elexacaftor/tezacaftor/ivacaftor therapy on mental health of patients with cystic fibrosis
Frontiers in Pharmacology
2023/4/21
Stephanie Thee
H-Index: 15
Effects of elexacaftor/tezacaftor/ivacaftor on sputum viscoelastic properties, airway infection and inflammation in patients with cystic fibrosis
Klinische Pädiatrie
2023/3
Stephanie Thee
H-Index: 15
Michael Gradzielski
H-Index: 33
Global estimates and determinants of antituberculosis drug pharmacokinetics in children and adolescents: a systematic review and individual patient data meta-analysis
2023/3/1
AMR-Lung: a European Clinical Research Collaboration on antimicrobial resistance in chronic lung disease
2023/12/1
Stephanie Thee
H-Index: 15
Anand Shah
H-Index: 10
A 5-year monocentric retrospective analysis of the use of Ceftazidim/Avibactam and Ceftolozane/Tazobactam in adult cystic fibrosis patients
2023/12/1
Stephanie Thee
H-Index: 15
Myeloperoxidase-dependent tyrosine halogenation potentiates alpha-defensins functions
bioRxiv
2023
Moritz Winkler
H-Index: 11
Stephanie Thee
H-Index: 15
Tuberkulose bei Kindern und Jugendlichen in Ländern mit niedriger Tuberkuloseinzidenz
2023
Stephanie Thee
H-Index: 15
130 Nasal nitric oxide increases in people with cystic fibrosis treated with elexacaftor-tezacaftor-ivacaftor
Journal of Cystic Fibrosis
2023/10/1
